Deltex confirms major monitor orders

Oesophageal doppler monitoring supplier Deltex Medical Group announced that it received confirmation of monitor orders worth over £0.2m on Thursday which, as indicated in the trading update announced on 18 January, had moved into 2017 due to the rescheduling of capital allocations in a small number of hospitals.

The AIM-traded company said the largest value sales contract was from the US, for six monitors from a seven hospital system in the company's Great Lakes sales territory.

It said the customer had originally planned to start implementation of ODM within its flagship hospital from April 2016 but, following delays in its procurement processes, had now decided to start implementation simultaneously in two additional hospitals.

The other major order was for 13 monitors from a consortium of NHS hospitals in the UK, comprising replacements for nine previously purchased monitors and four additional units.

“We are encouraged that we have been able to secure capital funding for our ODM monitors from major customers in both the US and the UK at a time of restricted capital budgets,” said chief executive Ewan Phillips.

“The US sales contract means we can now move forward with supporting implementation of ODM in one of the most prestigious of the US platform accounts we announced in 2016.”